Oxymetazoline hydrochloride 0.1% well tolerated for ptosis treatment

Oxymetazoline hydrochloride 0.1%, a preservative-free eye drop, was well tolerated and produced positive outcomes in the treatment of acquired ptosis, according to a study.
“Blepharoptosis (or ptosis) is an abnormal drooping of the upper eyelid margin with the eye in primary gaze,” Charles B. Slonim, MD, of the department of ophthalmology, University of South Florida Morsani College of Medicine, and colleagues wrote. “Standard of care is surgery, often targeting the upper eyelid retractor muscles. While effective in improving visual function and quality-of-life measures,

Full Story →